Interpreting the international trends in testicular seminoma and nonseminoma incidence

被引:92
作者
Bray, Freddie [1 ]
Ferlay, Jacques
Devesa, Susan S.
McGlynn, Katherine A.
Moller, Henrik
机构
[1] Canc Registry Norway, Inst Populat Based Canc Res, N-0310 Oslo, Norway
[2] Int Agcy Res Canc, F-69372 Lyon, France
[3] NCI, Bethesda, MD 20892 USA
[4] Kings Coll London, London WC2R 2LS, England
[5] London Sch Hyg & Trop Med, London WC1, England
来源
NATURE CLINICAL PRACTICE UROLOGY | 2006年 / 3卷 / 10期
关键词
epidemiology; germ cell; seminoma; testicular cancer; trends;
D O I
10.1038/ncpuro0606
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
There are considerable geographic, ethnic and temporal variations in the global incidence of testicular cancer. The disease mainly affects Western populations, with average rates in developed areas of the world six times higher than those in developing areas. About 500,000 new cases were diagnosed worldwide in 2002, with the vast majority being germ cell tumors and occurring in young adult males. Traditionally, these tumors are further classified into seminoma and nonseminoma. In this Review, trends in the incidence of germ cell tumors are examined using high-quality cancer-registry data from 41 populations within 14 countries worldwide. To assess whether trends of seminoma and nonseminoma incidence are similar, data were analyzed by birth cohort. These analyses should reveal similar trends if the 10-year difference in the clinical manifestation of cancer between subtypes is caused by differences in the speed of progression from the same early rate-limiting step to the onset of symptomatic disease. In each country, incidence has uniformly increased in successive generations born from around 1920 until very recently. Cohort-specific trends in seminoma incidence are similar to cohort-specific trends in nonseminoma incidence, lending support to the conclusion that the subtypes are epidemiologically and etiologically comparable. The findings presented are related to current theories and evidence regarding the determinants of testicular germ cell cancer.
引用
收藏
页码:532 / 543
页数:12
相关论文
共 53 条
[21]   Increasing incidence of testicular cancer worldwide: A review [J].
Huyghe, E ;
Matsuda, T ;
Thonneau, P .
JOURNAL OF UROLOGY, 2003, 170 (01) :5-11
[22]   Risk of testicular cancer in men with abnormal semen characteristics:: cohort study [J].
Jacobsen, R ;
Bostofte, E ;
Engholm, G ;
Hansen, J ;
Olsen, JH ;
Skakkebæk, NE ;
Moller, H .
BMJ-BRITISH MEDICAL JOURNAL, 2000, 321 (7264) :789-792
[23]   Trends in testicular cancer incidence in Vaud, Switzerland [J].
Levi, F ;
Te, VC ;
Randimbison, L ;
La Vecchia, C .
EUROPEAN JOURNAL OF CANCER PREVENTION, 2003, 12 (04) :347-349
[24]   Prevalence of testicular intraepithelial neoplasia in healthy males [J].
Linke, J ;
Loy, V ;
Dieckmann, KP .
JOURNAL OF UROLOGY, 2005, 173 (05) :1577-1579
[25]  
Looijenga LHJ, 2002, ANAL QUANT CYTOL, V24, P263
[26]   DECREASED TESTICULAR CANCER RISK IN MEN BORN IN WARTIME [J].
MOLLER, H .
JOURNAL OF THE NATIONAL CANCER INSTITUTE, 1989, 81 (21) :1668-1669
[27]   Risk of testicular cancer in subfertile men:: case-control study [J].
Moller, H ;
Skakkebæk, NE .
BMJ-BRITISH MEDICAL JOURNAL, 1999, 318 (7183) :559-562
[28]  
MOLLER H, 1993, EUR UROL, V23, P8
[29]   Epidemiology of gonadal germ cell cancer in males and females [J].
Moller, H ;
Evans, H .
APMIS, 2003, 111 (01) :43-48
[30]   Trends in incidence of testicular cancer and prostate cancer in Denmark [J].
Moller, H .
HUMAN REPRODUCTION, 2001, 16 (05) :1007-1011